The plasma level of RIG-1, as an RNase-L downstream molecule, were found to be higher in patients with mild cognitive impairment, suggesting that extracellular RIG-1 level may be involved in the incipient neurodegenerative disorders, such as Alzheimer’s disease [55]. Here, RNASEL is linked to Alzheimer disease.